Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
D000208:Acute Disease; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D001216:Asparagine / Q000494:pharmacology; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D002478:Cells, Cultured; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D056486:Chemical and Drug Induced Liver Injury; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007938:Leukemia / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008111:Liver Function Tests; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000494:pharmacology; D014633:Valine / Q000378:metabolism; D014750:Vincristine / Q000494:pharmacology
D014750:Vincristine; D001216:Asparagine; D001215:Asparaginase; D014633:Valine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin